TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD
NCT02766192 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2016-05-09
Summary
Background: The poor prognosis and public health burden of PTSD necessitates the development of more effective and broader treatment approaches. In the etiopathogenesis of PTSD, trauma memories become ingrained into key brain areas through conditioned learning and are triggered by various situations of daily life. The brain glutamate system plays a key role in the process of trauma learning and trauma memories via long-term potentiation. Ketamine administration modulates the glutamate system and has been used in the treatment of depression and PTSD. Previous studies demonstrate that a single low dose of ketamine rapidly improves symptoms of refractory PTSD and treatment resistant depression. Unfortunately the observed response is short-lived (4-7 days, maximum up to 2 weeks) and multiple doses often produce unacceptable side effects. TIMBER (Trauma Interventions using Mindfulness Based Extinction and Reconsolidation for trauma memory) psychotherapy, is a manualized and translational mindfulness based cognitive behavioral therapy specifically designed to target trauma memories and their expressions in PTSD patients. The placebo controlled pilot study examined the efficacy of a protocol combining a single infusion of low dose ketamine (0.5mg/kg) and TIMBER psychotherapy in subjects suffering from chronic PTSD. The objective of this pilot study was to optimize and individualize treatment of chronic PTSD using a rapid, effective, trauma specific, user friendly and inexpensive approach that uses cutting edge psychopharmacological combined with novel psychotherapeutic approaches.
Methodology: The randomized, double blind, placebo-controlled pilot study used a crossover design. Ten subjects with refractory PTSD were assigned to one of two arms: one arm (n=5) received combined ketamine infusion and TIMBER therapy (TIMBER-K arm) and the second (n=5) received combined placebo (normal saline) infusion and TIMBER therapy (TIMBER-P arm). All 10 subjects received a short version of TIMBER therapy after 10 minutes of onset of the infusion in which reactivation of trauma memories was initiated in a controlled manner using standardized scales and scripted narrative of the index trauma. This was followed by a standardized mindfulness based cognitive therapy module to quickly de-escalate the arousal symptoms followed by induction of detached observation and reappraisal of the trauma experience. After completion of the 40-min infusion, all subjects were trained on the full version of TIMBER therapy using methods of mindfulness based graded exposure therapy and a twice-daily schedule of home practice was initiated. The investigators are currently in a process of recruiting fifty more subjects to examine the effects in a larger sample.
Conditions
Interventions
- DRUG
- BEHAVIORAL
-
TIMBER Psychotherapy
- DRUG
-
Placebo (normal saline)
Sponsors & Collaborators
-
The Cooper Health System
lead OTHER
Principal Investigators
-
Basant Pradhan, MD · Cooper Health System
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
NCT04032301 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine Infusions for PTSD and Treatment-Resistant Depression
NCT02577250 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine Infusion Therapy for the Treatment of PTSD in Paramedics
NCT03947099 ·Status: COMPLETED
-
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
NCT06414356 ·Status: RECRUITING ·Phase: PHASE4
-
Theta-Burst Neuromodulation for PTSD
NCT02769312 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
NCT07009158 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Pathophysiological Understanding and Treatment of PTSD: an rTMS Approach
NCT03840369 ·Status: COMPLETED ·Phase: NA
-
Enhancing Week-long Psychological Treatment for PTSD With Ketamine
NCT05737693 ·Status: RECRUITING ·Phase: PHASE2
-
Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
NCT04550377 ·Status: RECRUITING ·Phase: PHASE2
-
Ketamine and Prolonged Exposure in PTSD
NCT03960658 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ketamine Treatment for PTSD and MDD in TBI
NCT06228391 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Targeted Accelerated TMS for Post-Traumatic Stress Disorder
NCT07245641 ·Status: RECRUITING ·Phase: NA
-
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
NCT05067244 ·Status: COMPLETED ·Phase: PHASE2
-
tDCS and Inhibitory Control in PTSD
NCT06100731 ·Status: COMPLETED ·Phase: NA
-
CAP-Ketamine for Antidepressant Resistant PTSD
NCT02655692 ·Status: COMPLETED ·Phase: PHASE2
-
Norepinephrine Transporter Availability in PTSD
NCT01799837 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Posttraumatic Stress Disorder (PTSD) in Adult Survivors of Early Chronic Interpersonal Trauma
NCT01443182 ·Status: COMPLETED ·Phase: NA
-
Sleep-directed Hypnosis As A Complement To Cognitive Processing Therapy (CPT) In Treating Posttraumatic Stress Disorder (PTSD)
NCT00725192 ·Status: UNKNOWN ·Phase: NA
-
MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD
NCT02876172 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
NCT04889664 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
NCT01178671 ·Status: COMPLETED ·Phase: PHASE4
-
Repetitive Transcranial Magnetic Stimulation Plus Reactivation Therapy Efficacy on PTSD Symptom Severity in Resistant PTSD
NCT06111976 ·Status: RECRUITING ·Phase: NA
-
Neuromodulation and Neurorehabilitation for mTBI
NCT03819608 ·Status: RECRUITING ·Phase: NA
-
Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy
NCT02727998 ·Status: TERMINATED ·Phase: PHASE2
-
MDMA-Assisted CBCT for PTSD vs CBCT RCT
NCT06044675 ·Status: RECRUITING ·Phase: PHASE2